| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.5 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |